Oxurion NV - Company Profile

All the sales intelligence you need on Oxurion NV in one solution.

Save hours of research time with a comprehensive
Sales Intelligence Solution.
Understand how Oxurion NV fits into your total
addressable market and Ideal Customer Profile.
Gain competitive edge with triggers that tell you
when and how to engage with Oxurion NV.

Oxurion NV: Premium Databases

Contact the team or request a demo to find out how our data can drive your business forward

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Headline	Published	Journalists
Showing 3 of 9 results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore	02 Feb 2023	Lorem
Oxurion in talks to add US sites to ongoing THR-317’s Phase II DME trial post enrollment completion, source says	07 May 2019	Shuan Sim
Oxurion welcomes CRO pitches for future ophthalmology trials with three drug candidates, CEO says	13 Feb 2019	Mariana Lenharo
Oncurious hires CRO Chiltern for Phase I/IIa pediatric brain cancer study, will seek private funding next year – execs	04 May 2016	-

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Drug Insights:

Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
Material intelligence on competitors, including breaking news
Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Gain a 360-degree view of Oxurion NV and make more informed decisions for your business

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer